This inventor holds 1 USPTO granted patent. Top assignee: Mylan Gmbh. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Abhijit Mukund Deshmukh: Innovator in Transdermal Therapeutic Systems
Introduction
Abhijit Mukund Deshmukh is a notable inventor based in Secunderabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of transdermal therapeutic systems. His innovative work focuses on improving the delivery of medications for neurological disorders.
Latest Patents
Abhijit holds a patent for a "Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders." This patent describes a transdermal therapeutic system (TTS) that contains pramipexole or related compounds. The system is designed to administer a single dose over an extended period, such as one week. It features an acrylic-based or silicone-based matrix layer that includes pramipexole at concentrations of at least about 5 wt. % of the matrix. This formulation is resistant to crystallization and discoloration of the active ingredient, even when stored for long periods.
Career Highlights
Abhijit is currently employed at Mylan GmbH, a global leader in generic and specialty pharmaceuticals. His work at Mylan has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
He collaborates with talented professionals in his field, including coworkers Prasanna Kumar and Vikram Bindra. Their combined expertise contributes to the advancement of innovative solutions in drug delivery systems.
Conclusion
Abhijit Mukund Deshmukh is a pioneering inventor whose work in transdermal therapeutic systems has the potential to significantly impact the treatment of neurological disorders. His dedication to innovation continues to drive advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
